|
Research and Markets: The Asthma, COPD & Allergic Rhinitis Market Outlook to 2015
Business Wire (press release) Global sales of asthma, COPD and allergic rhinitis drugs are expected to decline from $46bn in 2009 to $43bn in 2015, due to patent expiries on leading … |
View full post on asthma – Google News